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Abstract Duchenne muscular dystrophy (DMD) is a rare
pediatric neuromuscular disease associated with progres-
sive muscle degeneration and extensive care needs. Our
objective was to estimate the caregiver burden associated
with DMD. We made cross-sectional assessments of
caregiver health-related quality of life (HRQL) and burden
using the EuroQol EQ-5D, a Visual Analogue Scale
(VAS), the SF-12 Health Survey, and the Zarit Caregiver
Burden Interview (ZBI) administered online. Results were
stratified by disease stage (early/late ambulatory/non-am-
bulatory) and caregivers’ rating of patients’ health and
mental status. In total, caregivers to 770 patients partici-
pated. Mean EQ-5D utility ranged between 0.85 (95 % CI
0.82–0.88) and 0.77 (0.74–0.80) across ambulatory classes
and 0.88 (0.85–0.90) and 0.57 (0.39–0.74) across care-
givers’ rating of patients’ health and mental status. Mean
VAS score was 0.74 (0.73–0.75), mean SF-12 Mental
Health Component Summary score 44 (43–45), and mean
ZBI score 29 (28–30). Anxiety and depression, recorded in
up to 70 % of caregivers depending on patients’ health and
mental status, was significantly associated with annual
household cost burden ([$5000 vs. \$1000, odds ratio
1.76, 95 % CI 1.18–2.63) and hours of leisure time devoted
to informal care per week (25–50 vs. \25 h 2.01,
1.37–2.94; [50 vs. \25 h 3.35, 2.32–4.83) (p\ 0.007).
We show that caring for a person with DMD can be
associated with a substantial burden and impaired HRQL.
Our findings suggest that caregivers to patients with DMD
should be screened for depression and emphasize the need
for a holistic approach to family mental health in the
context of chronic childhood disease.
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Introduction
Throughout the Western world, including the US, Aus-
tralia, Japan, and the European Union, long-term care of
disabled or chronically ill patients is predominately pro-
vided at home by untrained, unpaid family members [1–4].
For many caregivers, assisting their spouse, parent, off-
spring, or other relative in their day-to-day life may be a
positive experience, but can at times also be tremendously
challenging. Numerous studies have shown that the pro-
vision of informal care is associated with serious adverse
health effects for the caregiver, including anxiety and
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depression, impaired immune system function, and coro-
nary heart disease, as well as social isolation, financial
deprivation, and even premature death [1, 5–7]. Existing
research, however, focus on the burden on caregivers to
elderly patients, predominantly with dementia, with less
attention devoted to genetic pediatric conditions, including
Duchenne muscular dystrophy (DMD).
DMD is a rare, X-linked, neuromuscular disease char-
acterized by progressive muscle weakening, diminishing
functional ability, and serious multisystem complications,
with a mean life expectancy of 25 years [8–10]. As a result
of the devastating disease progression, patients inevitably
transition towards a state of total dependency, requiring
wheelchairs for mobility from their early teens and venti-
lation support for survival in more advanced stages of the
disease. Many patients with DMD also suffer from mental
health comorbidities, such as autism spectrum disorder
(ASD) and obsessive–compulsive disorder (OCD). The
complexity of the disease necessitates multidisciplinary
management including regular visits to neuromuscular,
cardiac, and respiratory specialists, physiotherapists, and
other healthcare practitioners [8, 9].
We have previously reported that caring for a child with
DMD is both time-consuming and financially burdensome
[11]. Many DMD caregivers terminate their employment or
reduce their working hours to find the time needed to care
for their sons, and those who do continue to work have
markedly impaired productivity with high levels of
absenteeism. In addition to forgone income, depending on
national policies, affected households also carry substantial
costs associated with, e.g., insurance premiums and co-
payments for healthcare.
The caregiver burden has been studied in DMD only in
small samples from a single clinic or country, in combi-
nation with other muscle dystrophies, and/or without
stratifying results by disease stage or patient health status
[12–22]. The objective of this multinational study was to
complement our previous data on the objective caregiver
burden in DMD with estimates of the subjective burden:
that is, the impact on health-related quality of life (HRQL).
A specific aim was to investigate mental distress among
caregivers.
Methods
Participants and procedures
Caregivers to patients with DMD were recruited as part of
a multinational, cross-sectional, observational study for
which details and results have been previously reported
[11, 23]. In summary, patients with DMD from Germany,
Italy, the UK, and the US were recruited through national
DMD registries which form part of the global TREAT-
NMD network [24]. To be eligible, patients were required
to fulfill the following criteria: (1) male, (2) DMD diag-
nosis, and (3) age C5 years. Caregivers to eligible patients
were invited to complete a questionnaire online. All par-
ticipants provided informed consent and study approval
was granted from Ludwig-Maximilians-Universita¨t
Mu¨nchen (Germany), Comitato Etico IRCCS E. Medea,
Associazione La Nostra Famiglia (Italy), North East
Research Ethics Service, NHS (UK), the Western Institu-
tional Review Board (US), and the TREAT-NMD Global
Databases Oversight Committee.
Outcome measures
We assessed caregiver HRQL using the EuroQol EQ-5D-3L
(EQ-5D) [25], a Visual Analogue Scale (VAS), and the SF-12
Health Survey (SF-12) [26]. The EQ-5D is a generic HRQL
instrument encompassing five dimensions (mobility, self-care,
usual activities, pain/discomfort, and anxiety/depression),
each described in three levels. EQ-5D outcomes are linked to
preference values, known as utilities ranging from 0 = dead
to 1 = perfect health, derived from the general public. The
VAS was presented as a continuous response scale, ranging
from 0 = ‘‘worst imaginable health’’ to 1 = ‘‘best imagin-
able health’’, measuring self-perceived HRQL.
The SF-12 is a generic HRQL instrument comprising 12
questions, each described in three to five levels. SF-12
outcomes include two composite scores, the Physical
Component Summary Score (PCS) and the Mental Health
Component Summary Score (MCS), as well as eight sepa-
rate scores. The instrument uses norm-based scoring
(mean = 50, SD = 10) and values\43 or[56 are consid-
ered significantly different from the general population [26].
In addition to the HRQL instruments, we assessed the
caregiver burden using the Zarit Caregiver Burden Inter-
view (ZBI) [27]. The ZBI contains 22 questions, each
described in five levels (global score range from 0 = low
burden to 88 = high burden).
To investigate the possible association between patient
and caregiver HRQL, we also asked caregivers to rate their
sons’ current health (categories ranging from ‘‘excellent’’
to ‘‘poor’’) and mental status (categories ranging from
‘‘happy and interested in life’’ to ‘‘very unhappy’’).
Statistical analysis
We assessed mean EQ-5D utility using the recommended
and most robust valuation set derived through the time-
trade-off method [25] (results for other EQ-5D valuation
sets presented as supplemental material online), mean VAS
scores, mean global caregiver ZBI scores, and mean SF-12
PCS and MCS scores. We assessed and reported EQ-5D
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results for anxiety and depression separately as we
hypothesized that this domain would be most influenced by
the caregiver role.
We related our results to the progression of DMD by
classifying patients into four groups defined first in terms
of current ambulatory status and second in terms of age: (1)
early ambulatory (approx. age 5–7 years), (2) late ambu-
latory (approx. age 8–11 years), (3) early non-ambulatory
(approx. age 12–15 years), and (4) late non-ambulatory
(approx. 16 years of age, or older) [8, 9].
We compared our estimates with EQ-5D and VAS
general population reference data [28, 29] using Welch’s
t tests and Welch’s analysis-of-variance models. We fitted
five logistic regression models to test for differences in
anxiety and depression across patients’ ambulatory status
(model I), caregivers’ ratings (model II and III), and two
objective measures of the caregiver burden (annual
household cost burden and hours of leisure time devoted to
informal care [11]) (model IV and V). Goodness-of-fit was
assessed using Hosmer and Lemeshow’s test. All analyses
were conducted in Stata 14.
Results
Demographic statistics of the participating caregivers
(n = 770) are presented in Table 1. Patients had a mean
age of 14 years (median 12 years; interquartile range
9–17 years), 47 % (359 of 770) were wheelchair depen-
dent, 16 % (126 of 770) required ventilation support, and
63 % (486 of 770) were currently taking glucocorticoids.
Additional details of the study sample have been previ-
ously published [11, 23].
Prevalence of anxiety and depression
Half of all caregivers (383 of 770) reported being moder-
ately or extremely anxious or depressed, significantly
higher than general population reference data for individ-
uals aged 40–49 years across all investigated strata
(p\ 0.001 for all comparison) (Fig. 1). Adjusted logistic
regression results showed that anxiety and depression was
strongly associated with the caregivers’ rating of patients’
health and mental status, as well as measures of objective
burden (i.e., annual household cost burden and hours of
leisure time devoted to informal care), but not ambulatory
class (Table 2). The prevalence of anxiety and depression
was comparable across countries (p = 0.139).
Caregiver health-related quality of life
Mean EQ-5D utilities, ranging from 0 = dead to
1 = perfect health representing general public preferences
of HRQL, are presented in Fig. 2. The sex- and age-mat-
ched loss in caregiver utility in relation to the general
population was estimated at between 0.09 (95 % CI
0.07–0.11) and 0.14 (0.11–0.17) across ambulatory classes,
between 0.06 (0.04–0.07) and 0.18 (0.13–0.23) across
Table 1 Demographic statistics of the DMD caregivers (n = 770)
n (proportion %)
Country of residence
Germany 173 (22)
Italy 122 (16)
The UK 191 (25)
The US 284 (37)
Sex, female 609 (79)
Age, mean (SD) (years) 44 (8)
University degree 324 (42)
Marital status
Married/partner 656 (85)
Separated/divorced 75 (10)
Single 30 (4)
Widowed 9 (1)
Relationship to the patient
Parent 753 (98)
Other relative, friend, or partner 17 (2)
Current situation
Employed 469 (61)
Unemployed 257 (33)
Retired 26 (3)
Student 12 (2)
Sick leave ([3 months) 6 (1)
Household income classa
Poor 72 (9)
Middle class 615 (80)
Rich 83 (11)
Annual household cost burdenb
\$1000 380 (49)
$1000–$5000 170 (22)
[$5000 220 (29)
Hours of leisure time devoted to informal care (per week)
\25 294 (38)
25–50 203 (26)
[50 273 (35)
Additional household member with DMD 55 (7)
Because of rounding, percentages might not add up to 100 % exactly
a Poor income class:\60 % of national median equalized household
disposable income; rich income class:[200 % of national median
equalized household disposable income
b Include non-reimbursed payments for insurance premiums, co-
payments for medical and community services and medications, and
out-of-pocket payments for investments (e.g., non-reimbursed pay-
ments for medical and non-medical aids and devices and investments
to and reconstructions of the home)
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caregivers’ rating of their sons’ current health, and between
0.09 (0.07–0.10) and 0.30 (0.13–0.46) across caregivers’
rating of their sons’ current mental status. Compared with
general population reference data for individuals aged
40–49 years, a significantly larger proportion of DMD
caregivers reported having pain or discomfort (44 vs. 33 %,
p\ 0.001) and problems performing usual activities (18
vs. 16 %, p = 0.006). Additional EQ-5D utility results
available as supplemental material online.
Mean VAS scores, representing the caregivers’ subjec-
tive rating of their own HRQL ranging from 0 = ‘‘worst
imaginable health’’ to 1 = ‘‘best imaginable health’’, was
lower than the estimated EQ-5D utilities in all strata,
except for caregivers to patients rated to be very unhappy
(Fig. 2). Neither mean utilities nor VAS scores were sig-
nificantly different across countries.
Mean SF-12 MCS score, ranging from 0 to 100 where
higher score reflects higher HRQL, was estimated at 44 (95
% CI 43–45), ranging between 44 (42–45) and 46 (45–48)
across ambulatory classes, 48 (47–50) and 37 (35–40)
across the caregivers’ rating of their sons’ current heath,
and 46 (45–47) and 33 (26–40) across the caregivers’ rat-
ing of their sons’ current mental status. Mean PCS scores
were within the normal range in all strata.
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Fig. 1 Prevalence of anxiety and depression in DMD caregivers
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Subjective caregiver burden
The mean global ZBI score, ranging from 0 = low burden
to 88 = high burden, was estimated at 29 (95 % CI 28–30),
ranging between 25 (23–27) and 32 (30–34) across
ambulatory classes, 23 (21–25) and 38 (34–41) across the
caregivers’ rating of sons’ current health, and 26 (24–27)
and 41 (34–48) across the caregivers’ rating of sons’ cur-
rent mental status. Results from the ZBI, sorted by score
(i.e., extent of caregiver burden) for each question, are
presented in Fig. 3. Additional ZBI results available as
supplemental material online.
Discussion
Caregiver burden has received considerable attention in the
gerontology literature during recent decades, but relatively
few studies have investigated the impact on HRQL in
caregivers to children with chronic diseases. Compared
with adult caregivers of patients with diseases associated
with advanced age, such as dementia or Parkinson’s, par-
ents raising a child with a chronic illness may face even
greater challenges as they normally live together and have
no choice but to fully take on the caregiver role [1]. In
addition, as a result of improved survival in many child-
hood diseases, including DMD, the duration of informal
caregiving has increased considerably, in some indications
from years to several decades, with increased morbidity
and care needs in later stages of the patient’s life [30, 31].
For incurable, terminal, progressive conditions, awareness
of the devastating disease trajectory would also be expec-
ted to have serious adverse effects on caregiver mental
well-being, and for genetic diseases, there may also be
aspects of guilt.
The objective of this study was to investigate the sub-
jective caregiver burden associated with DMD. Overall,
half of all DMD caregivers in our sample indicated being
moderately or extremely anxious or depressed, and we also
found the mental health summary score from the SF-12 to
be significantly lower than general population reference
data. These result confirms previous findings of elevated
Table 2 Predictors of anxiety
and depression in DMD
caregivers
n Odds ratio (95 % CI)a p value
Model I: patients’ ambulatory status
Early ambulatory 155 1
Late ambulatory 256 1.08 (0.70–1.65) 0.742
Early non-ambulatory 154 1.04 (0.64–1.70) 0.873
Late non-ambulatory 205 0.93 (0.53–1.64) 0.807
Model II: caregiver perceptions’ of patients’ health
Excellent 145 1
Very good 321 1.53 (1.00–2.33) 0.049
Good 228 3.85 (2.40–6.20) \0.001
Fair/poor 76 5.87 (3.05–11.29) \0.001
Model III: caregivers’ perception of patients’ mental status
Happy and interested in life 455 1
Somewhat happy 239 1.85 (1.32–2.58) \0.001
Somewhat unhappy 63 4.67 (2.44–8.92) \0.001
Very unhappy 13 7.22 (1.79–29.09) 0.005
Model IV: annual household cost burden
\$1000 380 1
$1000–$5000 170 1.43 (0.95–2.16) 0.090
[$5000 220 1.76 (1.18–2.63) 0.006
Model V: hours of leisure time devoted to informal care (per week)
\25 294 1
25–50 203 2.01 (1.37–2.94) \0.001
[50 273 3.35 (2.32–4.83) \0.001
Hosmer and Lemeshow’s test indicated good fit of the models to the data
a Adjusted for country, caregiver sex, caregiver age, caregiver university degree, caregiver marital status,
additional household member with DMD, household income class, patient diagnosis for depression,
ADHD, ASD, and OCD, patient learning disabilities, patient glucocorticoid use, and patient-caregiver
relationship (parent vs. other)
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risks of depression and distress reported in caregivers to
children with DMD and Becker muscular dystrophy [15–
17], type 1 diabetes [32], and autism [33], as well as par-
enting stress in pediatric chronic illnesses [34]. We found
the prevalence of anxiety and depression to be comparable
over the course of disease progression but strongly asso-
ciated with the health and mental state of the patient as
perceived by the caregiver. Specifically, caregivers to
patients in fair/poor compared to excellent health had a
sixfold risk increase of anxiety and depression. Comparing
patients perceived as very unhappy and happy, we noted a
sevenfold risk increase. These data suggest that it may be
relevant to screen for anxiety and depression in caregivers
to patients with DMD, and that patients’ health and mental
status may be helpful predictors of caregiver distress.
To our knowledge, only one study has previously esti-
mated HRQL in DMD caregivers using the EQ-5D, and in
contrast to our findings, this study found the prevalence of
anxiety and depression comparable to the general popula-
tion [20]. Possible reasons for this discrepancy include
differences in sample size and patient demographics, as the
previous study was based on parents to 57 adult patients
with DMD (mean age 27 years).
We found overall caregiver HRQL, as measured by EQ-
5D utilities representing general population preferences, to
be markedly impaired and closely associated with patient
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Fig. 2 Caregiver health-related quality of life
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health and mental status, but not ambulatory class.
Specifically, the mean caregiver utility was recorded at
0.81, significantly lower than the only previous report in
DMD (0.87, p\ 0.001) [20], and we estimated the mean
age- and sex-matched disutility at between 0.06 and 0.30
across the investigated strata (mean in the pooled sample
was 0.11). This implies that the loss in HRQL among DMD
caregivers was similar to or greater than published disu-
tility estimates for patients suffering from very serious and
sometimes rapidly fatal diseases, including lung cancer and
schizophrenia (0.11), systemic lupus erythematosus (0.08),
and epilepsy (0.07) [35]. Given how insensitive the EQ-5D
appears to be to capture impairment in HRQL in many
conditions (e.g., breast and prostate cancer, asthma, and
myocardial infarction, all with disutilities below the mini-
mally important difference threshold of 0.074) [35, 36], the
considerable loss in utility observed in our study is both
surprising and noteworthy, and captures the exquisite
stresses associated with caring for a child with a chroni-
cally disabling and progressive condition, with an invari-
ably fatal outcome. The small change in utility and VAS
scores across ambulatory classes indicates that caregivers
may find ways to learn to cope with the disease and the
increasing levels of disability and morbidity associated
with the progression of DMD, and adjust their perception
of their own HRQL over time. As shown in Fig. 2, the
mean utility and VAS scores were in fact slightly higher
among caregivers to late compared to early non-ambula-
tory patients (although the differences were not statistically
different, p = 0.254 and 0.113, respectively), possibly
related to additional assistance from, e.g., nurses and other
healthcare practitioners when patients become more dis-
abled. Comparing results from the SF-12 and the EQ-5D, it
is also worth noting that the former indicated normal
physical health, whereas EQ-5D domains relating to pain
and discomfort and usual activities were found to be sig-
nificantly impaired in relation to the general population.
These inconsistent results may be explained by differences
in the design and scoring of the two instruments, but
warrants further research, in particular considering the
recognized notion that without mental health there can be
no true physical health [37].
Kenneson et al. show that employment outside of the
home is a predictor of stress in caregivers to boys with
DMD and Becker muscular dystrophy [16]. In line with
this finding, across countries, we have previously reported
that between 27 and 49 % of caregivers in our sample
reduced their working hours or stopped working com-
pletely due to their son’s DMD, and we have also estimated
the mean number of hours of leisure time devoted to
informal caregiving per week at between 33 and 44 [11].
Still, in the present study, depending on their rating of
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
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Are afraid what the future holds for relative
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Feels that doesn’t have as much privacy as would like, because of relative
Feels burdened in caring for relative
Feels that have lost control of life since relative’s illness
Feels strained when are around relative
Feels that relative asks for more help than he/she needs
Feels that relative currently affects relationships with other family…
Feels uncertain about what to do about relative
Feel angry towards relative when is around him/her
Wishes could leave the care of relative to someone else
Feels embarrassed over relative’s behaviour
Feels that will be unable to take care of relative much longer
Feels uncomfortable about having friends over, because of relative
Proporon of answers
Never Rarely Sometimes Quite frequently Nearly always
Fig. 3 Distribution of replies from the Zarit Caregiver Burden Interview
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patient well-being, between 12 and 40 % of caregivers
replied that they frequently or always felt that they should
be doing more for their son. We also found that between 57
and 86 % of caregivers frequently or always felt worried
about the future of their child, 26 and 69 % were stressed
between the demands of caring for the relative and trying to
meet other responsibilities for family or work, and 17 and
62 % that they did not have enough money to take care of
their son. Together with our findings that a high annual
household cost burden and[25 h of leisure time devoted to
informal care per week is associated with anxiety and
depression, these data emphasize that lack of resources
(i.e., time and money) is an important source of distress in
DMD caregivers.
We estimated the mean global ZBI score at 29, ranging
from 23 to 41 across investigated strata, which may be
compared with estimates from studies in other diseases, for
example neuromuscular diseases in general (23) [13],
irritable bowel syndrome (22) [38], Alzheimer’s disease
(29) [39], obsessive–compulsive disorder (29) [40], and
Parkinson’s disease (24) [41]. Although these findings
indicate that caring for a patient with DMD is burdensome,
it is difficult to further interpret the results as there is no
link between ZBI scores and subjective caregiver burden or
well-being. For example, to what extent are caregivers
burdened by the feeling that their sons are dependent on
them, or that they feel embarrassed over their sons’
behavior, or by not having as much privacy as they would
like? This would be expected to vary across caregivers, by
age, sex, cultural setting, and a range of other factors. In
other words, the ZBI scoring algorithm does not take into
account that the questions and response categories included
in the instrument may have a different impact on the self-
perceived burden of each caregiver.
Despite the negative impact on well-being, there is also
evidence that being a caregiver to an individual with DMD
can be a positive, rewarding experience. For example,
Pangalila et al. found that 95 % of DMD caregivers in their
sample regarded caring as enjoyable, and Magliano et al.
found that 88 % of caregivers to patients with muscle
dystrophies had got something positive out of the situation
[18, 20]. We did not specifically measure positive aspects
of caregiving in DMD, but we found some support for
these previous results in the ZBI, where 82 % of caregivers
never/rarely wished that they could leave the care of their
child to someone else, indicative of the devotion with
which these caregivers take on their responsibilities,
despite the levels of stress and demand.
Although the observational nature of our data prevents us
from drawing conclusions of causality, our results have
several implications for health policy. First, given the asso-
ciation between number of hours spent providing informal
care and caregiver mental health, respite care and similar
initiatives is urgently needed to help reduce the family bur-
den and improve caregiver well-being. Second, our results
suggest that many families caring for a person with DMD
require increased financial support to help shoulder the
considerable cost burden associated with the disease, of
particular importance given the association between annual
household costs and caregiver anxiety and depression
demonstrated in this study. It should be noted however that
some family caregivers may increase their spending because
they are feeling depressed or anxious (to help improve the
situation of their child), not vice versa. Third, psychosocial
support for caregivers and families must be improved,
especially given the poor coverage of these types of services
among patients as described in our previous work [23].
Primary strengths of our study include a multinational
sample, comprising patients with DMD only (as compared to
mixed cohorts of neuromuscular disorders), of sufficient power
to enablemeaningful stratification across both disease stage and
patients’ perceived health and mental status. We found patient
clinical data to be characteristic for the different ambulatory
classes and the distribution of age similar for responders and
non-responders (not reported), indicating that any discrepancy
between our patient sample and the general DMD population
would be limited.We chose to recruit patients via the TREAT-
NMD national DMD registries, which accept registration on a
voluntary basis from patients and families with a mutation-
confirmed diagnosis of DMD. Although participation in the
registries is family initiated, and therefore more likely to be
sought by motivated families, the registry-based approach
allowed an unbiased sample to be obtained with respect to
attendance at any one clinic or restriction to any one domain
with potentially different care practices. Our questionnaire was
returned with a mean response rate of 42 % which is compa-
rable to other surveys sent out via this kind of route: indeed it is
also worth pointing out that the response rate among those who
actually received a study invitation would be expected to be
notably higher as a result of, e.g., lost invitations due to recent
changes to email addresses and spam filters. This also means
that our burden estimates should be viewed as conservative, as
very distressed caregivers may not have had time nor energy to
participate. Despite some limitations in the methodology
therefore we believe that this strategy has given us the best
possible chance of a generalizable view of burden of care in
DMDand an unprecedented glimpse into a large sample size in
a rare disease.
Conclusions
We show that caring for a person with DMD can be
associated with a substantial burden and markedly
impaired HRQL. Our data underscore the need for
healthcare practitioners involved in the medical
J Neurol
123
management of DMD to also pay attention to caregiver
mental health, in particular when the health and mental
status of the patient is perceived as poor. Our findings
emphasize the need for a holistic approach to family
mental health in the context of chronic childhood disease.
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